Device Trial Radar · NCT01415154
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Mar 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
67
Actual
Start
Aug 2011
Primary completion
Sep 2013
Study completion Jul 2014
Sponsor
- Lead sponsor
- NeuroneticsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 11, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of scheduled maintenance Transcranial Magnetic Stimulation (TMS) treatment compared to on-demand TMS treatment for symptomatic worsening in patients who have shown a clinical response to acute TMS treatment.
Conditions
- Major Depressive Disorder
Interventions
NeuroStar TMSDevice
NeuroStar TMS treatmant - 120% of Observed MT, 10 pulses per second, 4 second on-time, 26 second off-time, 75 trains, 3,000 total pulses/sessions for 6 days. 3 treatments in taper week 1, 2 treatments in taper week 2 and 1 treatment in taper week 3.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients Maintaining a Sustained Response Throughout a 12 Month Maintenance Treatment Phase.Time frame: 12 month evaluation
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Rush University Medical Center
Chicago, Illinois
Sheppard Pratt Health System
Baltimore, Maryland
Premier Psychiatric Group, L.L.C.
Lincoln, Nebraska
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.